vs

Side-by-side financial comparison of Healthpeak Properties (DOC) and VISHAY INTERTECHNOLOGY INC (VSH). Click either name above to swap in a different company.

VISHAY INTERTECHNOLOGY INC is the larger business by last-quarter revenue ($800.9M vs $719.4M, roughly 1.1× Healthpeak Properties). Healthpeak Properties runs the higher net margin — 73.2% vs 0.1%, a 73.1% gap on every dollar of revenue. On growth, VISHAY INTERTECHNOLOGY INC posted the faster year-over-year revenue change (12.1% vs 3.1%). Healthpeak Properties produced more free cash flow last quarter ($357.0M vs $54.6M). Over the past eight quarters, Healthpeak Properties's revenue compounded faster (8.9% CAGR vs 3.6%).

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

Vishay Intertechnology, Inc. is an American manufacturer of discrete semiconductors and passive electronic components founded by Polish-born businessman Felix Zandman. Vishay has manufacturing plants in Israel, Asia, Europe, and the Americas where it produces rectifiers, diodes, MOSFETs, optoelectronics, selected integrated circuits, resistors, capacitors, and inductors. Vishay Intertechnology revenues for 2024 were $2.9 billion. At the end of 2024, Vishay had approximately 22,700 full-time e...

DOC vs VSH — Head-to-Head

Bigger by revenue
VSH
VSH
1.1× larger
VSH
$800.9M
$719.4M
DOC
Growing faster (revenue YoY)
VSH
VSH
+9.0% gap
VSH
12.1%
3.1%
DOC
Higher net margin
DOC
DOC
73.1% more per $
DOC
73.2%
0.1%
VSH
More free cash flow
DOC
DOC
$302.4M more FCF
DOC
$357.0M
$54.6M
VSH
Faster 2-yr revenue CAGR
DOC
DOC
Annualised
DOC
8.9%
3.6%
VSH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DOC
DOC
VSH
VSH
Revenue
$719.4M
$800.9M
Net Profit
$114.0M
$986.0K
Gross Margin
19.6%
Operating Margin
17.4%
1.8%
Net Margin
73.2%
0.1%
Revenue YoY
3.1%
12.1%
Net Profit YoY
2406.4%
101.5%
EPS (diluted)
$0.16
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOC
DOC
VSH
VSH
Q4 25
$719.4M
$800.9M
Q3 25
$705.9M
$790.6M
Q2 25
$694.3M
$762.3M
Q1 25
$702.9M
$715.2M
Q4 24
$698.0M
$714.7M
Q3 24
$700.4M
$735.4M
Q2 24
$695.5M
$741.2M
Q1 24
$606.6M
$746.3M
Net Profit
DOC
DOC
VSH
VSH
Q4 25
$114.0M
$986.0K
Q3 25
$-117.1M
$-7.9M
Q2 25
$31.7M
$2.0M
Q1 25
$42.8M
$-4.1M
Q4 24
$4.5M
$-66.1M
Q3 24
$85.9M
$-19.3M
Q2 24
$146.0M
$23.5M
Q1 24
$6.7M
$30.9M
Gross Margin
DOC
DOC
VSH
VSH
Q4 25
19.6%
Q3 25
58.6%
19.5%
Q2 25
60.2%
19.5%
Q1 25
61.1%
19.0%
Q4 24
60.3%
19.9%
Q3 24
60.0%
20.5%
Q2 24
60.6%
22.0%
Q1 24
59.8%
22.8%
Operating Margin
DOC
DOC
VSH
VSH
Q4 25
17.4%
1.8%
Q3 25
9.2%
2.4%
Q2 25
5.7%
2.9%
Q1 25
7.7%
0.1%
Q4 24
-2.2%
-7.9%
Q3 24
14.1%
-2.5%
Q2 24
22.3%
5.1%
Q1 24
3.7%
5.7%
Net Margin
DOC
DOC
VSH
VSH
Q4 25
73.2%
0.1%
Q3 25
-16.6%
-1.0%
Q2 25
4.6%
0.3%
Q1 25
6.1%
-0.6%
Q4 24
0.7%
-9.2%
Q3 24
12.3%
-2.6%
Q2 24
21.0%
3.2%
Q1 24
1.1%
4.1%
EPS (diluted)
DOC
DOC
VSH
VSH
Q4 25
$0.16
$0.01
Q3 25
$-0.17
$-0.06
Q2 25
$0.05
$0.01
Q1 25
$0.06
$-0.03
Q4 24
$0.02
$-0.48
Q3 24
$0.12
$-0.14
Q2 24
$0.21
$0.17
Q1 24
$0.01
$0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOC
DOC
VSH
VSH
Cash + ST InvestmentsLiquidity on hand
$467.5M
$515.0M
Total DebtLower is stronger
$9.8B
$950.9M
Stockholders' EquityBook value
$7.5B
$2.1B
Total Assets
$20.3B
$4.2B
Debt / EquityLower = less leverage
1.31×
0.46×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOC
DOC
VSH
VSH
Q4 25
$467.5M
$515.0M
Q3 25
$91.0M
$443.9M
Q2 25
$89.4M
$473.9M
Q1 25
$70.6M
$609.4M
Q4 24
$119.8M
$590.3M
Q3 24
$180.4M
$643.8M
Q2 24
$106.9M
$672.7M
Q1 24
$101.8M
$796.5M
Total Debt
DOC
DOC
VSH
VSH
Q4 25
$9.8B
$950.9M
Q3 25
$9.1B
$919.7M
Q2 25
$9.0B
$914.5M
Q1 25
$8.9B
$988.2M
Q4 24
$8.7B
$905.0M
Q3 24
$8.6B
$820.8M
Q2 24
$8.6B
$820.6M
Q1 24
$8.8B
$819.4M
Stockholders' Equity
DOC
DOC
VSH
VSH
Q4 25
$7.5B
$2.1B
Q3 25
$7.6B
$2.1B
Q2 25
$7.9B
$2.1B
Q1 25
$8.2B
$2.0B
Q4 24
$8.4B
$2.0B
Q3 24
$8.6B
$2.2B
Q2 24
$8.8B
$2.2B
Q1 24
$8.9B
$2.2B
Total Assets
DOC
DOC
VSH
VSH
Q4 25
$20.3B
$4.2B
Q3 25
$19.6B
$4.2B
Q2 25
$19.8B
$4.2B
Q1 25
$19.8B
$4.2B
Q4 24
$19.9B
$4.1B
Q3 24
$20.0B
$4.2B
Q2 24
$20.2B
$4.2B
Q1 24
$20.5B
$4.3B
Debt / Equity
DOC
DOC
VSH
VSH
Q4 25
1.31×
0.46×
Q3 25
1.20×
0.44×
Q2 25
1.14×
0.44×
Q1 25
1.08×
0.49×
Q4 24
1.04×
0.45×
Q3 24
1.00×
0.38×
Q2 24
0.98×
0.38×
Q1 24
0.99×
0.38×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOC
DOC
VSH
VSH
Operating Cash FlowLast quarter
$1.3B
$149.4M
Free Cash FlowOCF − Capex
$357.0M
$54.6M
FCF MarginFCF / Revenue
49.6%
6.8%
Capex IntensityCapex / Revenue
124.4%
11.8%
Cash ConversionOCF / Net Profit
10.99×
151.48×
TTM Free Cash FlowTrailing 4 quarters
$-89.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOC
DOC
VSH
VSH
Q4 25
$1.3B
$149.4M
Q3 25
$315.0M
$27.6M
Q2 25
$363.5M
$-8.8M
Q1 25
$279.4M
$16.1M
Q4 24
$1.1B
$67.7M
Q3 24
$318.2M
$50.6M
Q2 24
$316.2M
$-24.7M
Q1 24
$152.6M
$80.2M
Free Cash Flow
DOC
DOC
VSH
VSH
Q4 25
$357.0M
$54.6M
Q3 25
$-24.7M
Q2 25
$-73.4M
Q1 25
$-45.5M
Q4 24
$333.7M
$-77.2M
Q3 24
$-9.0M
Q2 24
$-87.3M
Q1 24
$27.1M
FCF Margin
DOC
DOC
VSH
VSH
Q4 25
49.6%
6.8%
Q3 25
-3.1%
Q2 25
-9.6%
Q1 25
-6.4%
Q4 24
47.8%
-10.8%
Q3 24
-1.2%
Q2 24
-11.8%
Q1 24
3.6%
Capex Intensity
DOC
DOC
VSH
VSH
Q4 25
124.4%
11.8%
Q3 25
6.6%
Q2 25
8.5%
Q1 25
8.6%
Q4 24
105.6%
20.3%
Q3 24
8.1%
Q2 24
8.4%
Q1 24
7.1%
Cash Conversion
DOC
DOC
VSH
VSH
Q4 25
10.99×
151.48×
Q3 25
Q2 25
11.48×
-4.39×
Q1 25
6.52×
Q4 24
235.43×
Q3 24
3.71×
Q2 24
2.17×
-1.05×
Q1 24
22.85×
2.59×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DOC
DOC

Segment breakdown not available.

VSH
VSH

Resistors Segment$189.4M24%
Diodes Segment$154.2M19%
Capacitors Segment$136.5M17%
Other$126.4M16%
Inductors Segment$92.6M12%
Optoelectronic Components Segment$55.7M7%
EMS Companies$51.6M6%

Related Comparisons